# Personalized Dual-target RTMS for Patients with Refractory Schizophrenia

> **NCT06732817** · NA · COMPLETED · sponsor: **Anhui Medical University** · enrollment: 20 (actual)

## Conditions studied

- Schizophrenia
- Transcranial Magnetic Stimulation
- Functional Magnetic Resonance Imaging (fMRI)

## Interventions

- **DEVICE:** Active rTMS was administered using a transcranial magnetic stimulator (Rapid2; MagStim).

## Key facts

- **NCT ID:** NCT06732817
- **Lead sponsor:** Anhui Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-01
- **Primary completion:** 2024-10-31
- **Final completion:** 2024-10-31
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06732817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06732817, "Personalized Dual-target RTMS for Patients with Refractory Schizophrenia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06732817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*